Invesco Pharmaceuticals ETF (PJP) Dividend Yield, History & Forecast

Invesco Pharmaceuticals ETF (PJP) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 0.85% ($1.06 per share annually (TTM)). The most recent ex-dividend date was June 22, 2026, with payment scheduled for June 26, 2026. market capitalization is approximately $352M.

PJP fund composition

PJP holds 29 positions, with 48.8% of assets in its ten largest. It charges an expense ratio of 0.57%, and manages $488.2M.

Top 10 holdings

HoldingWeight
ABTAbbott Laboratories5.62%
AMGNAmgen Inc5.34%
ABBVAbbVie Inc5.29%
JNJJohnson & Johnson5.09%
MRKMerck & Co Inc4.91%
LLYEli Lilly & Co4.82%
CORTCorcept Therapeutics Inc4.70%
GILDGilead Sciences Inc4.65%
PFEPfizer Inc4.59%
LQDALiquidia Corp3.80%

Sector allocation

Healthcare100.0%

Frequently Asked Questions about Invesco Pharmaceuticals ETF (PJP)

What is Invesco Pharmaceuticals ETF's dividend yield?
Invesco Pharmaceuticals ETF (PJP) pays a current trailing twelve-month dividend yield of 0.85%, which works out to $1.06 per share annually based on the most recent payout schedule.
When does Invesco Pharmaceuticals ETF pay distributions?
The most recent ex-dividend date was June 22, 2026. The next scheduled dividend payment date is June 26, 2026.
How many years has Invesco Pharmaceuticals ETF increased its dividend?
Invesco Pharmaceuticals ETF (PJP) has increased its dividend for 8 consecutive years.
What does Invesco Pharmaceuticals ETF invest in?
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.